App-Quantinova.ai

ANTI-B2GLYCOPROTEIN-1 IGA ANTIBODIES INDEPENDENTLY AND DIFFERENTIALLY CONTRIBUTE TO THROMBOTIC RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS ABOVE AND BEYOND ACL AND LA: LESSONS FROM A CONTEMPORARY MULTIETHNIC PATIENT COHORT

T. Aung - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE

R. Demetrio Pablo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Aspirin

ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY ANALYSIS: THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS ON THE CLINICAL PHENOTYPE OF ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS

S. Zuily - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

THE RISK OF PULMONARY EMBOLISM AND DEEP VENOUS THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UNITED KINGDOM: A POPULATION-BASED STUDY

A. Jorge - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ALTERED CUTANEOUS MICROVASCULAR FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

K. Perdan Pirkmajer - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroprusside sodium

ANTI-C1Q AUTOANTIBODIES, C1Q CIRCULATING IMMUNE COMPLEXES AND COMPLEMENT LEVELS IN PATIENTS WITH NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

C. Magro-Checa - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

AUTOIMMUNE HEMOLYTIC ANEMIA AND THROMBOCYTOPENIA IN A SINGLE CENTRE COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM TURKEY: CLINICAL ASSOCIATIONS AND EFFECT ON DISEASE DAMAGE AND SURVIVAL

B. Artim-Esen - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

IS HYPERURICEMIA AN INDEPENDENT RISK FACTOR FOR ARTERIAL THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS?

C.C. Mok - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

COAGULATION FACTOR XIII MIGHT BE A PROMISING MARKER FOR PREDICTING ATHEROSCLEROSIS IN SLE

I. Matsuura - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Angiotensin II

THROMBOCYTOPENIA IS A THROMBOTIC RISK FACTOR IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE?

R. Demetrio Pablo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A CASE SERIES WITH A LONG-TERM FOLLOW-UP

M. Estevez - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

THE ASSOCIATION BETWEEN ABO BLOOD TYPES AND VENOUS THROMBOEMBOLISM IN INDIVIDUALS WITH A POSITIVE ANTIPHOSPHOLIPID PROFILE IS VARIED BY SEX

M. Shusterman - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Warfarin

CARRIAGE FREQUENCY OF HAPTOGLOBIN PHENOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND THEIR ASSOCIATION WITH CLINICAL MANIFESTATIONS

M. Sultanova - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

B. Artim-Esen - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

OCULAR POSTERIOR SEGMENT FINDINGS IN ANTIPHOSPHOLIPID SYNDROME

E. Kucukkomurcu - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Fluorescein sodium

ANTI-PHOSPHOLIPID POSITIVITY IN HEALTHY SUBJECTS: EVALUATION OF RISK FOR THROMBOTIC EVENT AFTER A 5 YEARS FOLLOW-UP

F. Ceccarelli - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

COMPARATIVE STUDY OF RISK FACTORS FOR VENOUS AND ARTERIAL THROMBOSIS IN CARRIERS OF ANTIPHOSPHOLIPID ANTIBODIES

I. Les - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

SEROLOGICAL EVOLUTION IN FERTILE WOMEN WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES

L. Riancho-Zarrabeitia - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Aspirin

RISK FACTORS FOR PREGNANCY MORBIDITY IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES WITHOUT A DEFINED CLINICAL ANTIPHOSPHOLIPID SYNDROME

R. Demetrio Pablo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ASSESSMENT OF MEAN PLATELET VOLUME AS A MARKER OF DISEASE ACTIVITY IN SLE PATIENTS

L.T. Hartmann - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Filters

7277 Abstracts